Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.4.0.3
Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Operating expenses:    
Research and development $ 4,430,670 $ 2,422,106
General and administrative 4,724,133 2,272,970
Total operating expenses 9,154,803 4,695,076
Loss from operations (9,154,803) (4,695,076)
Other income (expense):    
Interest income 43,371 55,368
Change in fair value of warrant liabilities 188,270 (212,055)
Total other income (expense) 231,641 (156,687)
Net loss $ (8,923,162) $ (4,851,763)
Per share information:    
Net loss per share of common stock, basic and diluted $ (0.32) $ (0.24)
Basic and diluted weighted average shares outstanding 27,483,909 20,221,463